Bank of Japan Eyes Further Rate Hikes Amid Middle East Tensions and Inflation Pressures 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Citigroup Delays Fed Rate Cut Forecast Amid Strong Jobs Data and Inflation Concerns 
Trump's FY2027 Budget: Major Defense Boost and Domestic Spending Cuts 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
U.S. Warplane Shot Down by Iran Amid Escalating Middle East Conflict 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
U.S. Stock Futures Stabilize Ahead of Good Friday as Investors Eye Jobs Report 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Kellogg will spend a cumulative pre-tax amount of approximately $45 million to increase productivity by shifting production to optimal lines across its North American supply chain network.
According to Kellogg spokesperson Kris Bahner, some of their locations are better-performing and more cost-effective, so they should shift capacity there to increase efficiency, cut costs, and be more competitive.
Productivity improvements are expected by 2023, with the overall project set to be fundamentally completed by early 2024.
No production facilities are set to close as a result.
The investment is subject to collective bargaining obligations, and Kellogg is setting aside $4 million to cover employee-related costs, such as including severance and other termination benefits.
